NASDAQ · Drug Manufacturers - Specialty & Generic
Lantheus Holdings Inc (LNTH)
$102.10
0.00%
68
In band
Moving averages
SMA 200$92.59+10.27%
Company profile
Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$6.64B
P/E ratio25.27
EPS$4.02
Beta0.025
Dividend yield0.00%
52-week high$111.86
52-week low$51.80
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 27
CGC
Canopy Growth Corporation
RSI 21
BFRI
Biofrontera Inc
RSI 31
TLRY
Tilray Brands Inc - Class 2
RSI 27
BCRX
Biocryst Pharmaceuticals Inc
RSI 37
ACB
Aurora Cannabis Inc
RSI 45
ORGO
Organogenesis Holdings Inc - Class A
RSI 38
INM
InMed Pharmaceuticals Inc
RSI 54
RSI alerts for LNTH
An email when LNTH closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 6:07 AM EST